| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/21/2009 | CN101347558A Chinese medicine for treating rheumatism osteonosus |
| 01/21/2009 | CN101347555A Medicinal liquor for treating waist and leg aches induced by protrusion of lumbar vertebral disc |
| 01/21/2009 | CN101347549A Medicament composition for treating intumescence and infection contamination of navel section of newborn infant as well as preparation method thereof |
| 01/21/2009 | CN101347539A Medicament for treating ache of joint and preparation thereof |
| 01/21/2009 | CN101347536A External-use preparation for treating traumatic injury |
| 01/21/2009 | CN101347520A 'Wan an' health-care paste for dispelling pain |
| 01/21/2009 | CN101347516A Method for preparing total free anthraquinones extract from rhubarb |
| 01/21/2009 | CN101347515A Quick-acting antalgic plaster for detoxication and detumescence |
| 01/21/2009 | CN101347514A Health medical pillow |
| 01/21/2009 | CN101347512A Macleaya cordata injection and preparation thereof |
| 01/21/2009 | CN101347507A Medicament composition for treating traumatology disease and preparation, use, medicinal preparation and quality control method thereof |
| 01/21/2009 | CN101347505A Chai huang granule and uses thereof |
| 01/21/2009 | CN101347487A Chinese medicine external-use decoction for dispelling wind |
| 01/21/2009 | CN101347477A Medicament composition for treating rheumatoid arthritis |
| 01/21/2009 | CN101347469A Composition containing extracts of Butyrospermum parkii and the use as medicament or dietary supplement |
| 01/21/2009 | CN101347411A Ibuprofen suspension and method of preparing the same |
| 01/21/2009 | CN101347408A Kukoline intravenous transfusion preparation |
| 01/21/2009 | CN101347256A Sugar-free corn tassel drink and method for preparing corn tassel drink as well as use |
| 01/21/2009 | CN101347167A Freezing beverage containing reed rhizome and method of preparing the same |
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/21/2009 | CN100453530C Compounds and methods for inhibition of expression of VCAM-1 |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100453106C Chinese medicine compound preparation for treating laryngopharyngitis and tonsillitis and its preparing method |
| 01/21/2009 | CN100453104C Natural botanical extraction liquid for preventing and treating epidemic febrile disease of birds and livestock and method for preparing same |
| 01/21/2009 | CN100453080C Lindera root alkaloid, its preparation method and application in medicine preparation |
| 01/21/2009 | CN100453078C Method for treating primary insomnia |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479508 Nimesulide containing topical pharmaceutical compositions |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479503 Such as multiple sclerosis; also inactivating HIV virus via extracorporeal treatment of blood; use of a green porphyrin or porfimer sodium |
| 01/20/2009 | US7479492 Use combined 5-HT1A agonists and selective serotonin reuptake inhibitors |
| 01/20/2009 | US7479280 Papilloma virus capsid support comprising chimeric lymphocyte epitope for use in identifying modulators to treat and prevention cell proiferative, autoimmune and viral diseases |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2465871C Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2365240C Regulation of phospholipase d activity |
| 01/20/2009 | CA2344411C 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 01/20/2009 | CA2338794C New oral formulation for 5-ht4 agonists or antagonists |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2289880C A therapeutic agent for intractable vasculitis |
| 01/20/2009 | CA2271693C Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/20/2009 | CA2246344C A solid non-effervescent compressed dosage form containing racemic ibuprofen |
| 01/15/2009 | WO2009009740A1 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation |
| 01/15/2009 | WO2009009587A2 Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same |
| 01/15/2009 | WO2009009550A1 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | WO2009007750A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | WO2009007680A2 Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders |
| 01/15/2009 | WO2009007673A2 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008140251A3 Cyclooxygenase-2 inhibitors |
| 01/15/2009 | WO2008119790A3 Use of fluoride-containing compounds for diagnostic purposes with the help of imaging processes |
| 01/15/2009 | WO2008112483A3 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
| 01/15/2009 | WO2008110699A3 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 01/15/2009 | WO2008109532A4 Nucleic acid compounds for inhibiting fas gene expression and uses thereof |
| 01/15/2009 | WO2007114827A8 Substituted heterocyclic compounds and methods of use |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018314 low affinity receptor for IgE (FceRII/CD23); for modulating or inhibiting induced IgE expression; allergic conditions, autoimmune and inflammatory diseases |
| 01/15/2009 | US20090018211 Method for inhibiting of COX2 and inflammation with phenolic aldehydes |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018158 Crystal forms of an imidazole derivative |
| 01/15/2009 | US20090018154 Opioid and methods of making and using the same |
| 01/15/2009 | US20090018147 Compounds for modulating TRPV3 function |
| 01/15/2009 | US20090018138 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018128 Compounds |
| 01/15/2009 | US20090018125 Pharmaceutical Composition and Its Use |
| 01/15/2009 | US20090018120 Amidine derivatives and their applications as a medicament |
| 01/15/2009 | US20090018119 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 01/15/2009 | US20090018114 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | US20090018104 Triarylcarboxylic Acid Derivative |
| 01/15/2009 | US20090018089 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 01/15/2009 | US20090018078 Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090017129 Dead Sea minerals enriched anti-inflammatory pharmaceutical composition for treatment of cutaneous dryness, itching, peeling and tightness, especially in hemodialysis patients and preparation and treatment methods thereof |
| 01/15/2009 | US20090017071 Methods for treating neurogenic inflammation |
| 01/15/2009 | US20090017049 BetaGBP, compositions comprising betaGBP, and related methods and uses thereof |
| 01/15/2009 | US20090017033 Inhibiting receptor activated nuclear factor kappa beta ligand (RANKL); immunoregulation |
| 01/15/2009 | US20090017032 Mammalian cx3c chemokine antibodies |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017018 Uses of mammalian cytokine: related reagents |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090016987 Pharmaceutical composition and therapeutic method |
| 01/15/2009 | CA2693628A1 New combination for use in the treatment of imflammatory disorders |
| 01/15/2009 | CA2692761A1 Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation |
| 01/15/2009 | CA2692720A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | CA2690756A1 Novel compounds as cannabinoid receptor ligands |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014679A1 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014678A2 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014653A1 Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
| 01/14/2009 | EP2014291A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 01/14/2009 | EP2014284A1 Pharmaceutical compositions and uses |
| 01/14/2009 | EP2014283A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same |
| 01/14/2009 | EP2013211A2 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/14/2009 | EP2013210A1 Purine derivatives with activity to the adenosine a2a receptor |
| 01/14/2009 | EP2013195A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials. |